Background: Adherence to topical corticosteroids is low among atopic dermatitis
| INTRODUCTION
Atopic dermatitis is a chronic inflammatory skin condition, common among children aged between 0 and 5 years old. In the Netherlands, 8%-14% of all children are diagnosed with atopic dermatitis. 1 Atopic dermatitis can cause significant morbidity in the affected child, 2 even
on an emotional and psychosocial functional level. 3 Moreover, the condition severely impacts the family through increased disruption. 4 Although it is difficult to establish the financial costs of atopic dermatitis to society, it has been estimated that the economic burden is considerable. 2 Treatment of atopic dermatitis consists of the application of emollients and topical corticosteroids. Although topical corticosteroids are safe and effective, adherence is low. 5 Only 32% of DOI: 10.1111/pde.13698 patients with atopic dermatitis follow the medical prescriptions. 6 Low adherence can lead to treatment failure and a subsequent decrease in quality of life. 6, 7 One of the causes of low topical corticosteroids adherence is fears and concerns about corticosteroids, known as "corticophobia."
The term corticophobia describes exaggerated concerns, fears, wor- We used the Topicop questionnaire, consisting of questions addressing the worries and beliefs regarding topical corticosteroids to assess topical corticophobia among parents of atopic dermatitis patients and professionals. 12 Several studies indicate that this questionnaire is applicable for patients and parents in different settings and can be used internationally. 8, 13, 14 The current study assesses and compares the worries and beliefs concerning topical corticosteroids of parents of children with atopic dermatitis and involved health care professionals, and between different professionals. Finally, we sought factors associated with corticophobia in professionals.
| ME TH ODS

| Study design and subjects
This cross-sectional study was conducted between February and July 2017. All patients with atopic dermatitis aged between 0 and 5 years old in the Medical Centre Leeuwarden were identified via electronic patient records. The children had to be under active care of dermatologists or pediatricians and had to be receiving treatment.
Parents could participate if they were the primary applier of topical corticosteroids and spoke Dutch fluently. We contacted the parents by telephone, explained the aim of the study, and then sent the questionnaire.
Public health care nurses, GPs, public health care physicians, and pediatricians employed in the north of the Netherlands and who spoke Dutch fluently were invited to participate also. They were approached during meetings. After explanation of the aim of the study, the questionnaire was given.
Incomplete questionnaires or questionnaires including multiple answers to one question were excluded.
| Questionnaire
All the participants were invited to complete a questionnaire consisting of two sections. The first section contained demographic characteristics. Some questions differed for the professionals and the parents since they have different roles.
The second section was the Topicop questionnaire. This questionnaire is validated for use with atopic dermatitis patients and their parents, including 12 items assessing the worries and beliefs concerning topical corticosteroids that were scored on a 4-point scale varying from "totally disagree" to "totally agree" (score 0-3). Higher scores correspond to more severe corticophobia. The six items concerning worries add up to a sum score for worries; the other six items, concerning beliefs, add up to a sum score for beliefs. These two scores together add up to the final score, ranging from zero to 36, expressed as a percentage. 12 For this study, the questionnaire was translated into Dutch. Professionals were asked to answer the questions as if they were using topical corticosteroids on their own child. The questionnaire was available both on paper and digitally.
| Sample size
The calculations for the required sample size were based on a study by Gonzales, 13 in which an average corticophobia score of 37% was found, with a standard deviation of 19%. A difference of 14% (5 points) was considered clinically relevant. Using a two-sided independent sample t test with a significance level of 5% to achieve 80% power, every group had to have at least 27 participants.
| Statistics
To assess whether there is a difference in the Topicop sum score between parents, public health care nurses, public health care physicians, GPs, and pediatricians, we used the Kruskal-Wallis test and the Mann-Whitney U test for post hoc analysis; P < 0.05 was considered statistically significant, and P < 0.005 was considered significant according to the Bonferroni correction adjusting for multiple comparisons.
Linear regression analysis was used to identify factors associated with the Topicop sum score within professionals only.
For all analyses, we assumed data were independent. For the multivariable linear regression model, we assessed whether the residuals were homoscedastic and normally distributed. For continuous predictors, we additionally assessed linearity of the association with the Topicop score, while dummy variables were created for categorical variables such as type of profession. Finally, we assessed whether there were outliers and if so, whether this affected our conclusion by performing a sensitivity analyses in which the outlier was excluded.
All the variables (demographic characteristics and the type of profession) univariately associated with corticophobia (P < 0.05)
were entered into the multivariate linear regression. All the variables (age, years in profession, sex, child with atopic dermatitis, and the type of profession) univariably associated with corticophobia (P < 0.05) were entered into the multivariable linear regression model. Subsequently, variables with a P value ≥ 0.05 in the multivariate model were excluded until all independent variables had P < 0.05. All analyses were performed using SPSS version 24.0.0.0, (IBM corp. Armonk, NY).
| Ethics
This study was submitted to a legally constituted ethics committee, the Medical Ethical Research Committee of the Medical Centre Leeuwarden, which provided an exemption for the need of a waiver for the current study. Care was taken to protect privacy by processing the questionnaires anonymously. The participants did not receive any compensation for their involvement.
| RESULTS
A total of 205 questionnaires were submitted, 14 were excluded because of incompleteness, and 191 were analyzed. Of those analyzed, 29 were from parents and 162 from professionals: 31 public health care nurses, 33 public health care physicians, 51 general practitioners, and 47 pediatricians.
Of the participants, 136 (70%) were female. The parents had a median age of 32 (with a minimum-maximum age of 23-50), and the professionals had a median age of 52 (22-71). A slight majority of the professionals did not have a child with AD (53%). Of the parents, 94% had an education level of "Intermediate vocational education" or higher (Table 1 ).
The median of the sum score on the Topicop measure from high to low was parents (44%), public health care nurses (44%), general practitioners (39%), public health care physicians (31%), and pediatricians (31%) (Figure 1) . A higher score indicates more severe corticophobia.
The sum scores for parents were significantly higher compared with those of all the professionals (P ≤ 0.001), except for public health care nurses (P = 0.56) (Figure 1 ). In contrast, the sum scores for pediatricians were significantly lower compared with parents, public health care nurses, and general practitioners, but similar to public health care physicians.
Finally, among the professionals, type of profession and having a child with atopic dermatitis were significantly associated with the sum score. Having a child with atopic dermatitis was associated with a lower sum score. Age and sex were not significantly associated with the sum score. In the multivariate regression after correction for confounders, the differences between the professionals did not change.
| DISCUSSION
This study is the first to compare corticophobia for atopic dermatitis in parents of young children and among health care professionals.
Parents of children with atopic dermatitis and public health care nurses displayed the highest levels of corticophobia, while pediatricians and public health care physicians had the lowest levels. Health care professionals who have a child with atopic dermatitis displayed significantly less corticophobia compared with those without a child with atopic dermatitis.
Corticophobia among parents has a negative influence on the adherence to topical corticosteroids. 6, [8] [9] [10] It is important to provide Age of child in years [median (min-max]) 2 (0-5) n/a n /a n /a n /a A limitation of this study is that the Topicop questionnaire was not developed for use with health care professionals. Therefore, we asked the professionals to imagine having a child with atopic dermatitis although we did not validate this. Another limitation is that this Dutch translation of the Topicop is not validated. However, this does not seem to have influenced our findings since the mean Topicop sum score of parents in the current study was similar to Stadler. 19 Furthermore, we used the questionnaire to compare groups.
In conclusion, our findings confirm that corticophobia is present in parents of children with atopic dermatitis and in health care professionals, especially health care nurses. This may affect the perspectives of parents and topical corticosteroids adherence negatively.
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